ProMed Pharma announces acquisition of SpineThera
SpineThera, Inc., a privately held, clinical-stage pharmaceutical company focused on the development of SX600 (1a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain) and ProMed Pharma LLC, a leading contract manufacturer of polymer-based drug releasing dosage forms and combination device components, announced yesterday that ProMed Pharma has acquired […]
Takeda and Biological E. Limited team up to provide Dengue Vaccine in endemic areas
Takeda and Biological E. Limited (BE), a leading India-based Vaccines and Pharmaceutical Company, yesterday announced a strategic partnership to accelerate access to QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials (MDVs). These doses will ultimately be made available for procurement by governments in endemic countries by 2030 at the latest to support National Immunization Programs. […]
Pharmanovia acquires Global CNS Portfolio From Sanofi
Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, recently announced the expansion of its neurology portfolio with the acquisition of 11 central nervous system (CNS) brands from global healthcare company, Sanofi. The brands span four therapy areas of ongoing unmet need associated with CNS […]
Veracyte welcomes Marie-Claire Taine as General Manager IVD Business Unit
Veracyte, Inc. announced that Marie-Claire Taine, Ph.D., will join Veracyte as general manager of the company’s in vitro diagnostics (IVD) Business Unit, based in Marseille, France. She will lead the global expansion of Veracyte’s tests and will also serve as site lead for the company’s Marseille operations. Dr. Taine is a highly credentialed commercial operations leader with […]
Nippon Express enters into partnership with Pharma.Aero
Nippon Express (Belgium) NV/SA (hereinafter “NX Belgium”), a group company of Nippon Express Holdings inc, became the first Japanese freight forwarder to enter this Year Pharma.Aero. Nippon Express Group has positioned the pharmaceutical industry as a key industry in its “Nippon Express Group Business Plan 2023 Dynamic Growth” and pursues the global development of a […]
